Molina Healthcare, Inc. (MOH)
USD 296.59
(1.65%)
USD 296.59
(1.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 34.07 Billion USD | 6.56% |
| 2022 | 31.97 Billion USD | 15.13% |
| 2021 | 27.77 Billion USD | 42.98% |
| 2020 | 19.42 Billion USD | 15.41% |
| 2019 | 16.82 Billion USD | -10.91% |
| 2018 | 18.89 Billion USD | -4.99% |
| 2017 | 19.88 Billion USD | 12.26% |
| 2016 | 17.71 Billion USD | 25.86% |
| 2015 | 14.07 Billion USD | 45.57% |
| 2014 | 9.66 Billion USD | 46.71% |
| 2013 | 6.58 Billion USD | 9.29% |
| 2012 | 6.02 Billion USD | 26.39% |
| 2011 | 4.76 Billion USD | 16.74% |
| 2010 | 4.08 Billion USD | 11.35% |
| 2009 | 3.66 Billion USD | 17.9% |
| 2008 | 3.11 Billion USD | 24.87% |
| 2007 | 2.49 Billion USD | 24.31% |
| 2006 | 2 Billion USD | 21.51% |
| 2005 | 1.65 Billion USD | 40.4% |
| 2004 | 1.17 Billion USD | 48.1% |
| 2003 | 793.54 Million USD | 23.18% |
| 2002 | 644.19 Million USD | 27.85% |
| 2001 | 503.85 Million USD | 52.95% |
| 2000 | 329.43 Million USD | 77.34% |
| 1999 | 185.76 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 9.93 Billion USD | 9.76% |
| 2024 Q2 | 9.85 Billion USD | -0.73% |
| 2024 Q3 | 10.34 Billion USD | 4.88% |
| 2023 Q3 | 8.54 Billion USD | 2.65% |
| 2023 Q4 | 9.04 Billion USD | 5.85% |
| 2023 Q1 | 8.14 Billion USD | -0.9% |
| 2023 Q2 | 8.32 Billion USD | 2.18% |
| 2023 FY | 34.07 Billion USD | 6.56% |
| 2022 Q1 | 7.77 Billion USD | 4.87% |
| 2022 Q3 | 7.92 Billion USD | -1.58% |
| 2022 Q4 | 8.22 Billion USD | 3.73% |
| 2022 FY | 31.97 Billion USD | 15.13% |
| 2022 Q2 | 8.05 Billion USD | 3.66% |
| 2021 Q4 | 7.4 Billion USD | 5.24% |
| 2021 Q1 | 6.52 Billion USD | 24.58% |
| 2021 FY | 27.77 Billion USD | 42.98% |
| 2021 Q2 | 6.8 Billion USD | 4.26% |
| 2021 Q3 | 7.04 Billion USD | 3.53% |
| 2020 Q2 | 4.61 Billion USD | 1.52% |
| 2020 FY | 19.42 Billion USD | 15.41% |
| 2020 Q1 | 4.54 Billion USD | 6.43% |
| 2020 Q4 | 5.23 Billion USD | 4.26% |
| 2020 Q3 | 5.02 Billion USD | 8.73% |
| 2019 FY | 16.82 Billion USD | -10.91% |
| 2019 Q1 | 4.11 Billion USD | -11.69% |
| 2019 Q2 | 4.19 Billion USD | 1.8% |
| 2019 Q4 | 4.27 Billion USD | 0.73% |
| 2019 Q3 | 4.24 Billion USD | 1.19% |
| 2018 FY | 18.89 Billion USD | -4.99% |
| 2018 Q4 | 4.66 Billion USD | -0.7% |
| 2018 Q2 | 4.88 Billion USD | 5.1% |
| 2018 Q1 | 4.64 Billion USD | -6.12% |
| 2018 Q3 | 4.69 Billion USD | -3.81% |
| 2017 Q2 | 4.99 Billion USD | 1.94% |
| 2017 Q1 | 4.9 Billion USD | 9.88% |
| 2017 FY | 19.88 Billion USD | 12.26% |
| 2017 Q3 | 5.03 Billion USD | 0.64% |
| 2017 Q4 | 4.94 Billion USD | -1.63% |
| 2016 Q1 | 4.34 Billion USD | 15.35% |
| 2016 Q3 | 4.54 Billion USD | 4.29% |
| 2016 Q4 | 4.46 Billion USD | -1.83% |
| 2016 Q2 | 4.35 Billion USD | 0.37% |
| 2016 FY | 17.71 Billion USD | 25.86% |
| 2015 Q2 | 3.52 Billion USD | 11.16% |
| 2015 Q4 | 3.76 Billion USD | 4.25% |
| 2015 Q3 | 3.61 Billion USD | 2.45% |
| 2015 Q1 | 3.17 Billion USD | 13.22% |
| 2015 FY | 14.07 Billion USD | 45.57% |
| 2014 FY | 9.66 Billion USD | 46.71% |
| 2014 Q4 | 2.8 Billion USD | 12.74% |
| 2014 Q3 | 2.48 Billion USD | 7.45% |
| 2014 Q2 | 2.31 Billion USD | 11.73% |
| 2014 Q1 | 2.06 Billion USD | 21.32% |
| 2013 Q4 | 1.7 Billion USD | 1.1% |
| 2013 Q2 | 1.6 Billion USD | 0.96% |
| 2013 Q3 | 1.68 Billion USD | 5.06% |
| 2013 Q1 | 1.59 Billion USD | 0.76% |
| 2013 FY | 6.58 Billion USD | 9.29% |
| 2012 Q3 | 1.54 Billion USD | 0.32% |
| 2012 Q4 | 1.57 Billion USD | 2.49% |
| 2012 Q2 | 1.53 Billion USD | 11.77% |
| 2012 Q1 | 1.37 Billion USD | 5.14% |
| 2012 FY | 6.02 Billion USD | 26.39% |
| 2011 Q2 | 1.16 Billion USD | 4.23% |
| 2011 FY | 4.76 Billion USD | 16.74% |
| 2011 Q4 | 1.3 Billion USD | 11.02% |
| 2011 Q3 | 1.17 Billion USD | 0.82% |
| 2011 Q1 | 1.11 Billion USD | 3.6% |
| 2010 FY | 4.08 Billion USD | 11.35% |
| 2010 Q2 | 999.33 Million USD | 3.37% |
| 2010 Q1 | 966.74 Million USD | 0.26% |
| 2010 Q3 | 1.03 Billion USD | 3.98% |
| 2010 Q4 | 1.08 Billion USD | 4.0% |
| 2009 FY | 3.66 Billion USD | 17.9% |
| 2009 Q1 | 861.03 Million USD | 5.97% |
| 2009 Q2 | 927.58 Million USD | 7.73% |
| 2009 Q3 | 916.51 Million USD | -1.19% |
| 2009 Q4 | 964.22 Million USD | 5.21% |
| 2008 Q2 | 766.49 Million USD | 4.0% |
| 2008 Q1 | 737.04 Million USD | 8.45% |
| 2008 FY | 3.11 Billion USD | 24.87% |
| 2008 Q4 | 812.5 Million USD | 2.03% |
| 2008 Q3 | 796.32 Million USD | 3.89% |
| 2007 FY | 2.49 Billion USD | 24.31% |
| 2007 Q3 | 636.03 Million USD | 3.61% |
| 2007 Q2 | 613.88 Million USD | 9.06% |
| 2007 Q1 | 562.9 Million USD | 2.44% |
| 2007 Q4 | 679.62 Million USD | 6.85% |
| 2006 Q1 | 453.37 Million USD | 7.13% |
| 2006 Q3 | 517.46 Million USD | 6.77% |
| 2006 Q4 | 549.52 Million USD | 6.19% |
| 2006 FY | 2 Billion USD | 21.51% |
| 2006 Q2 | 484.63 Million USD | 6.89% |
| 2005 FY | 1.65 Billion USD | 40.4% |
| 2005 Q2 | 404.27 Million USD | 2.62% |
| 2005 Q1 | 393.95 Million USD | 4.95% |
| 2005 Q4 | 423.22 Million USD | -1.26% |
| 2005 Q3 | 428.61 Million USD | 6.02% |
| 2004 Q3 | 330.8 Million USD | 32.82% |
| 2004 Q4 | 375.37 Million USD | 13.47% |
| 2004 FY | 1.17 Billion USD | 48.1% |
| 2004 Q2 | 249.05 Million USD | 13.19% |
| 2004 Q1 | 220.02 Million USD | 5.31% |
| 2003 Q1 | 192.16 Million USD | 0.0% |
| 2003 FY | 793.54 Million USD | 23.18% |
| 2003 Q4 | 208.92 Million USD | 5.77% |
| 2003 Q3 | 197.52 Million USD | 1.3% |
| 2003 Q2 | 194.98 Million USD | 1.47% |
| 2002 FY | 644.19 Million USD | 27.85% |
| 2001 FY | 503.85 Million USD | 52.95% |
| 2000 FY | 329.43 Million USD | 77.34% |
| 1999 FY | 185.76 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cigna Corporation | 195.18 Billion USD | 82.544% |
| Centene Corporation | 153.99 Billion USD | 77.875% |
| CVS Health Corporation | 357.77 Billion USD | 90.477% |
| Elevance Health Inc. | 171.34 Billion USD | 80.114% |
| Humana Inc. | 106.37 Billion USD | 67.97% |
| Oscar Health, Inc. | 5.86 Billion USD | -481.149% |
| UnitedHealth Group Incorporated | 371.62 Billion USD | 90.832% |